Sponsor Dossier
GlaxoSmithKline
Sponsor Dossier for GlaxoSmithKline. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AIRZATE ACCUHALER
- Brand: ANORO
- Brand: AREXVY
- Brand: ARNUITY ELLIPTA
- Brand: AVAMYS
- Brand: AVODART
- Brand: AXOTIDE
- Brand: BACTROBAN
- Device (sponsor): Medicine chamber spacer
- Device (sponsor): Curette Dermal
- Device (sponsor): Skin-coring punch, single-use
About
GlaxoSmithKline is an Australian Private Company with ABN 47 100 162 481, registered in Victoria. The company is Active and operates under the trading names GSK Melbourne, Stiefel (a GSK Company), Allen and Hanburys, and GlaxoSmithKline Consumer Healthcare.
Portfolio
GlaxoSmithKline has 49 brands on the ARTG, of which 47 are indexable and 46 carry a Product Information document. 19 brands are PBS-listed, 29 have a PBAC outcome on record, and 19 have an AusPAR on record. Notable brands include AIRZATE ACCUHALER, ANORO, AREXVY, ARNUITY ELLIPTA, AVAMYS, AVODART, AXOTIDE, BACTROBAN, BENLYSTA, BEXSERO, BLENREP, BOOSTRIX.
Therapeutic focus
— Infectious Disease: 22 brands — Respiratory: 16 brands — Oncology: 3 brands — Reproductive Health: 3 brands — Dermatology: 2 brands — Cardiology: 1 brand — Immunology: 1 brand — Haematology: 1 brand
PBS footprint
19 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 29 brands with a PBAC outcome on record. The latest AusPAR is 2026-10-12, across 19 brands with an AusPAR on record.